Medicinal plants have been of great importance to many traditional communities for many generations. However, there is need to carry out scientific studies in order to confirm the medicinal properties of many plants used traditionally. Cosmos sulphureus (Asteraceae) used by local communities for the treatment of various diseases has showed antioxidant, antibacterial, antifungal and antiplasmodial properties although there are no studies demonstrating its antionchocerca activity. The present study was undertaken to investigate the antionchocerca potential of crude extracts and chromatographic fractions of C. sulphureus using Onchocerca ochengi, a bovine filarial closest in phylogeny to Onchocerca volvulus. Solvent extraction of the parts of C. sulphureus was performed using distilled water, 70% EtOH, MeOH, CH 2 Cl 2 and a mixture of MeOH/CH 2 Cl 2 (v/v). Anthelmintic assay was evaluated on adult worms of O. ochengi and worm viability was assessed biochemically using the dimethylthiazol (MTT) formazan assay. Acute and sub-acute oral toxicities of the promising extract was investigated in mice. The chemical composition of extracts was revealed. EtOH extract of roots showed highest anthelmintic activity with an LC 50 value of 31.01±1.17 µg/mL which was more significant than the one of ivermectin (LC 50 =42.78 µg/mL) used as standard. The other extracts show moderate activities. The most active fraction obtained from EtOH extract of roots had an LC 50 value of 19.10 µg/mL on male worm. For acute toxicity, a single dose of 2000 mg/kg used induced no critical behavioral changes or death. In sub-acute toxicity, daily oral administration of hydro-ethanolic extracts of roots at the dose of 250, 500 and 750 mg/kg revealed disturbances in the normal growth of animals as well as liver and kidney alterations. These results unfold potential sources of novel anti-onchocerca lead compounds and validate the traditional use of the plants in onchocerciasis treatment.
Background
During the last two decades research on animal filarial parasites, especially Onchocerca ochengi, infecting cattle in savanna areas of Africa revealed that O. ochengi as an animal model has biological features that are similar to those of O. volvulus, the aetiological agent of human onchocerciasis. There is, however, a paucity of biochemical, immunological and pathological data for O. ochengi. Galectins can be generated by parasites and their hosts. They are multifunctional molecules affecting the interaction between filarial parasites and their mammalian hosts including immune responses. This study characterized O. ochengi galectin, verified its immunologenicity and established its immune reactivity and that of Onchocerca volvulus galectin.
Results
The phylogenetic analysis showed the high degree of identity between the identified O. ochengi and the O. volvulus galectin-1 (ß-galactoside-binding protein-1) consisting only in one exchange of alanine for serine. O. ochengi galectin induced IgG antibodies during 28 days after immunization of Wistar rats. IgG from O. ochengi-infected cattle and O. volvulus-infected humans cross-reacted with the corresponding galectins. Under the applied experimental conditions in a cell proliferation test, O. ochengi galectin failed to significantly stimulate peripheral blood mononuclear cells (PBMCs) from O. ochengi-infected cattle, regardless of their parasite load.
Conclusion
An O. ochengi galectin gene was identified and the recombinantly expressed protein was immunogenic. IgG from Onchocerca-infected humans and cattle showed similar cross-reaction with both respective galectins. The present findings reflect the phylogenetic relationship between the two parasites and endorse the appropriateness of the cattle O. ochengi model for O. volvulus infection research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.